Inner ear disease due to hair cell loss is common, and no restorative treatments for the balance and hearing impairment are currently available. To develop clinical means for enhancing protection and regeneration in the inner ear, it is necessary to understand the molecular basis for hereditary and acquired deafness and vestibular disorders. One approach is to identify and characterize genes that regulate protection or repair in other systems. For that purpose, we have used the differential display assay and compared gene expression between normal and acoustically traumatized inner ears of chicks. Several chick cDNAs that were identified are considered as candidates for roles in the reparative process that follows trauma in the basilar papilla. The mammalian vestibular epithelium has a limited regenerative capability. To identify genes that may participate in the regenerative response, we have used gene arrays profiling, comparing normal to drug-traumatized vestibular epithelia. We identified several genes that are differentially expressed in traumatized vestibular epithelium, including several insulin-like growth factor-I binding proteins. To use this molecular knowledge for enhancing protection and repair in the organ of Corti, it is necessary to overexpress the genes of choice in the inner ear. Using viral-mediated gene transfer, we overexpressed transgenic glial cell line-derived neurotrophic factor and demonstrated a robust protective effect against acoustic and ototoxic inner ear trauma. Future identification of the genes that are important for protection and regeneration, along with improved gene transfer technology, will allow the use of gene therapy for treating hereditary and environmental inner ear disease.

1.
Adler HJ, Raphael Y: New hair cells arise from supporting cell conversion in the acoustically damaged chick inner ear. Neurosci Lett 1996;205:17–20.
2.
Adler HJ, Winnicki RS, Gong TW, Lomax MI: A gene upregulated in the acoustically damaged chick basilar papilla encodes a novel WD40 repeat protein. Genomics 1999;56:59–69.
3.
Derby ML, Sena-Esteves M, Breakefield XO, Corey DP: Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res 1999;134:1–8.
4.
Forge A, Li L, Corwin JT, Nevill G: Ultrastructural evidence for hair cell regeneration in the mammalian inner ear. Science 1993;259:1616–1619.
5.
Gong TW, Hegeman AD, Shin JJ, Adler HJ, Raphael Y, Lomax MI: Identification of genes expressed after noise exposure in the chick basilar papilla. Hear Res 1996;96:20–32.
6.
Hegarty JL, Kay AR, Green SH: Trophic support of cultured spiral ganglion neurons by depolarization exceeds and is additive with that by neurotrophins or cAMP and requires elevation of [Ca2+]i within a set range. J Neurosci 1997;17:1959–1970.
7.
Holt JR, Johns DC, Wang S, Chen ZY, Dunn RJ, Marban E, Corey DP: Functional expression of exogenous proteins in mammalian sensory hair cells infected with adenoviral vectors. J Neurophysiol 1999;81:1881–1888.
8.
Keithley EM, Ma CL, Ryan AF, Louis JC, Magal E: GDNF protects the cochlea against noise damage. Neuroreport 1998;9:2183–2187.
9.
Lalwani A, Walsh B, Reilly P, Carvalho G, Zolotukhin S, Muzyczka N, Mhatre A: Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther 1998;5:277–281.
10.
Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F: GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1130–1132.
11.
Lin LF, Zhang TJ, Collins F, Armes LG: Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J Neurochem 1994;63:758–768.
12.
Lomax MI, Huang L, Cho Y, Gong T-WL, Altschuler RA: Differential display and gene arrays to examine auditory plasticity. Hear Res 2000;147:293–302.
13.
Lopez I, Honrubia V, Lee SC, Schoeman G, Beykirch K: Quantification of the process of hair cell loss and recovery in the chinchilla crista ampullaris after gentamicin treatment. Int J Dev Neurosci 1997;15:447–461.
14.
Oesterle EC, Hume CR: Growth factor regulation of the cell cycle in developing and mature inner ear sensory epithelia. J Neurocytol 1999;28:877–887.
15.
Prieskorn D, Dootz G, Yagi M, Miller JM, Dolan DF, Raphael Y: GDNF Gene Therapy against Acoustic Trauma in Guinea Pigs. Midwinter Meet Assoc for Res in Otolaryngol, St Petersburg Beach, 1999.
16.
Roberson DW, Kreig CS, Rubel EW: Light microscopic evidence that direct transdifferentiation gives rise to new hair cells in regenerating avian auditory epithelium. Aud Neurosci 1996;2:195–205.
17.
Shoji F, Miller AL, Mitchell A, Yamasoba T, Altschuler RA, Miller JM: Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hear Res 2000;146:134–142.
18.
Staecker H, Gabaizadeh R, Federoff H, Van De Water TR: Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 1998;119:7–13.
19.
Stone JS, Oesterle EC, Rubel EW: Recent insights into regeneration of auditory and vestibular hair cells. Curr Opin Neurol 1998;11:17–24.
20.
Stöver T, Gong TL, Cho Y, Altschuler RA, Lomax MI: Expression of the GDNF family members and their receptors in the mature rat cochlea. Brain Res Mol Brain Res 2000;76:25–35.
21.
Stöver T, Yagi M, Raphael Y: Cochlear gene transfer: Round window versus cochleostomy inoculation. Hear Res 1999;136:124–130.
22.
Stöver T, Yagi M, Raphael Y: Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther 2000;7:377–383.
23.
Suzuki M, Yagi M, Brown JN, Miller AL, Miller JM, Raphael Y: Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Ther 2000;7:1046–1054.
24.
Warchol ME, Lambert PR, Goldstein BJ, Forge A, Corwin JT: Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans. Science 1993;259:1619–1622.
25.
Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y: Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum Gene Ther 1999;10:813–823.
26.
Yagi M, Shah P, Magal E, Sheng Z, Raphael Y: Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. JARO 2000;1:315–325.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.